Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteases and emphysema.

Andrew Churg1, Joanne L Wright

  • 1Department of Pathology, University of British Columbia, Vancouver, BC, Canada. achurg@interchange.ubc.ca

Current Opinion in Pulmonary Medicine
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis.

Annals of the American Thoracic Society·2026
Same author

TSC2, cathepsin K, and β-catenin as immunohistochemical markers for lymphangioleiomyomatosis.

Human pathology·2026
Same author

Update on pleural epithelioid mesothelioma: New insights for diagnosis and patient management.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Treatable traits in interstitial lung disease: towards precision medicine.

Thorax·2026
Same author

Glutamine fructose 6-phosphate transaminase-2 as a marker of mesothelial proliferations.

Histopathology·2026
Same author

Association of CT Features with Radiologic Patterns in Interstitial Lung Disease: Multinomial Analysis in CARE-PF.

Radiology·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
Same journal

Molecular mechanisms of environmental risk factors for interstitial lung disease.

Current opinion in pulmonary medicine·2026
See all related articles

The protease-antiprotease theory of emphysema is complex, involving interactions between various proteases and inflammatory cells. Animal models suggest antiproteolytic therapy can help treat cigarette smoke-induced emphysema.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • The protease-antiprotease theory of emphysema is widely accepted.
  • Identifying specific cells and proteases involved in emphysema pathogenesis remains controversial.

Purpose of the Study:

  • To review the current understanding of the cellular and molecular mechanisms underlying emphysema.
  • To explore the roles of various proteases and inflammatory mediators in emphysema development.

Main Methods:

  • Review of human studies and laboratory animal models of emphysema.
  • Analysis of protease activity (metalloproteinases, serine elastases) and inflammatory mediator signaling (TNF-alpha, IL-13).
  • Investigation of genetic modifications and their impact on emphysema development.

Related Experiment Videos

Main Results:

  • Human studies show increased metalloproteinase activity in emphysema.
  • Animal models highlight the crucial role of neutrophils and matrix metalloproteinase-12 (MMP12) in driving emphysema.
  • Interference with neutrophil elastase and tumor necrosis factor-alpha signaling offers protection; metalloproteinase inhibitors may provide greater benefit.
  • Genetic models demonstrate emphysema induction via mediators like tumor necrosis factor-alpha, with evidence of multiple protease attacks and collagen breakdown.

Conclusions:

  • Emphysema pathogenesis likely involves complex interactions among multiple proteases and inflammatory mediators, not a single agent.
  • Relevance of animal models to human emphysema requires careful consideration due to potential discrepancies in protease roles.
  • Antiproteolytic therapy shows promise in ameliorating cigarette smoke-induced emphysema based on animal model evidence.